Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies
(2015)
Journal Article
Monoclonal antibodies represent the most successful class of biopharmaceuticals for the treatment of cancer. Mechanisms of action of therapeutic antibodies are very diverse and reflect their ability to engage in antibody-dependent effector mechanisms... Read More about Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies.